Compare ATYR & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATYR | PRPL |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | 58 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 76.9M |
| IPO Year | N/A | 2015 |
| Metric | ATYR | PRPL |
|---|---|---|
| Price | $0.83 | $0.66 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $3.67 | $0.85 |
| AVG Volume (30 Days) | ★ 948.2K | 301.2K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 152.75 |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $468,725,000.00 |
| Revenue This Year | N/A | $10.83 |
| Revenue Next Year | N/A | $6.81 |
| P/E Ratio | ★ N/A | $1.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $0.57 |
| 52 Week High | $7.29 | $1.26 |
| Indicator | ATYR | PRPL |
|---|---|---|
| Relative Strength Index (RSI) | 50.11 | 52.09 |
| Support Level | $0.68 | $0.65 |
| Resistance Level | $0.86 | $0.73 |
| Average True Range (ATR) | 0.05 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 68.00 | 59.24 |
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.